Related Experiment Video
Updated: Aug 5, 2026

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
Published on: February 23, 2018
H5N1 influenza binding and cell entry via human class II MHC, and blocking by cross-reactive antibodies
Taylor Pursell1,2, Artem Mikelov2, Oliver F Wirz2
1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94304, USA.
Abstract:
Highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b viruses are currently responsible for a multi-species outbreak affecting wild birds, poultry, numerous mammalian species, and humans. Influenza A viruses typically initiate infection through binding to sialic acid, although select bat and human influenza viruses can also exploit class II major histocompatibility complex (MHC-II) molecules for cell entry. Here we show that emerging H5N1 clade 2.3.4.4b viruses, but not historical H5 lineages, bind human MHC-II HLA-DR and mediate sialic acid-independent cell entry. Hemagglutinin binding to primary human immune cells varies with MHC-II expression and is further shaped by HLA-DR allelic variation, identifying host genetic determinants that may influence susceptibility to infection. Mammalian-adaptive substitutions within the hemagglutinin sialic acid receptor-binding domain reduce MHC-II binding, suggesting this interaction is remodeled during clade 2.3.4.4b H5 adaptation to a human host. Lastly, cross-reactive monoclonal antibodies isolated from clade 2.3.4.4b H5-naive humans can block the hemagglutinin-MHC-II interaction. These findings identify a previously unrecognized receptor pathway in contemporary H5N1 viruses and reveal that both human genetic variation and pre-existing humoral immunity can modulate this interaction, with implications for host range, cellular tropism, spillover risk, and therapeutic intervention.
Insights
Emerging H5N1 avian influenza viruses bind human immune cells via MHC-II, independent of sialic acid. This interaction, influenced by host genetics, offers new therapeutic targets against H5N1 virus infections.
Area of Science:
- Virology and Immunology
- Molecular Biology
- Genetics
Background:
- Highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b viruses are causing a widespread, multi-species outbreak.
- Influenza A viruses typically use sialic acid for cell entry, but some utilize major histocompatibility complex class II (MHC-II) molecules.
Purpose of the Study:
- To investigate the cell entry mechanisms of emerging H5N1 clade 2.3.4.4b viruses.
- To determine if these viruses can bind to human MHC-II molecules and mediate sialic acid-independent cell entry.
- To explore the role of host genetic variation and pre-existing immunity in H5N1 infection susceptibility and potential therapeutic interventions.
Main Methods:
- Analysis of hemagglutinin binding to human MHC-II HLA-DR.
- Assessment of sialic acid-independent cell entry mediated by H5N1 clade 2.3.4.4b viruses.
- Investigation of the impact of mammalian-adaptive substitutions on MHC-II binding.
- Characterization of cross-reactive monoclonal antibodies for blocking HA-MHC-II interaction.
Main Results:
- Emerging H5N1 clade 2.3.4.4b viruses bind human MHC-II HLA-DR and enter cells independently of sialic acid, unlike historical H5 lineages.
- Hemagglutinin binding affinity varies with MHC-II expression and HLA-DR allelic variation, indicating host genetic influence on susceptibility.
- Mammalian-adaptive mutations in the hemagglutinin reduce MHC-II binding, suggesting adaptation to human hosts remodels this interaction.
- Monoclonal antibodies from H5N1-naive humans can block the hemagglutinin-MHC-II interaction.
Conclusions:
- Contemporary H5N1 viruses utilize a novel receptor pathway involving human MHC-II for cell entry.
- Host genetic diversity and pre-existing humoral immunity modulate H5N1 interactions, impacting viral host range and spillover risk.
- The HA-MHC-II interaction presents a potential target for therapeutic interventions against H5N1 avian influenza.
Related Concept Videos
Influenza
Inhibitors Of Virion Release
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viral Recombination
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Leaky Scanning

